tiprankstipranks
Bolt Biotherapeutics (BOLT)
NASDAQ:BOLT
US Market
BOLT
Bolt Biotherapeutics
RESEARCH TOOLSreports
Want to see BOLT full AI Analyst Report?

Bolt Biotherapeutics (BOLT) Stock News & Sentiment

246 Followers
Buy Rating on Bolt Biotherapeutics Driven by Differentiated Claudin 18.2 ISAC BDC-4182 and Solid Cash Runway to 2027
Premium
Ratings
Buy Rating on Bolt Biotherapeutics Driven by Differentiated Claudin 18.2 ISAC BDC-4182 and Solid Cash Runway to 2027
2M ago
BOLT
Buy Rating for Bolt Biotherapeutics: Innovative Approach and Strong Financials Drive Positive Outlook
Premium
Ratings
Buy Rating for Bolt Biotherapeutics: Innovative Approach and Strong Financials Drive Positive Outlook
6M ago
BOLT
Bolt Biotherapeutics Reports Improved Financial Performance
Premium
Company Announcements
Bolt Biotherapeutics Reports Improved Financial Performance
6M ago
BOLT
Bolt Biotherapeutics’ Pioneering Study on BDC-4182: A New Hope for Cancer Treatment
Premium
Company Announcements
Bolt Biotherapeutics’ Pioneering Study on BDC-4182: A New Hope for Cancer Treatment
7M ago
BOLT
Buy Rating for Bolt Biotherapeutics: Innovative Cancer Treatment Approach and Strategic Financial Management
Premium
Ratings
Buy Rating for Bolt Biotherapeutics: Innovative Cancer Treatment Approach and Strategic Financial Management
7M ago
BOLT
Bolt Biotherapeutics Announces Major Restructuring Plan
Premium
Company Announcements
Bolt Biotherapeutics Announces Major Restructuring Plan
8M ago
8K
BOLT
Bolt Biotherapeutics Reports Reduced Losses and Revenue Growth
Premium
Company Announcements
Bolt Biotherapeutics Reports Reduced Losses and Revenue Growth
9M ago
BOLT
More BOLT News >

BOLT News on the Web

JonesTrading Keeps Their Hold Rating on Bolt Biotherapeutics (BOLT)
TipRanks News
Neutral
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Buy Rating on Bolt Biotherapeutics Driven by Differentiated Claudin 18.2 ISAC BDC-4182 and Solid Cash Runway to 2027
TipRanks News
Bullish
Bolt Biotherapeutics, Inc. (BOLT) Reports Q4 Loss, Tops Revenue Estimates
Zacks
Bullish
Bolt Biotherapeutics reports Q4 EPS ($3.84), consensus ($5.52)
TipRanks News
Bullish
Bolt Reports Q3 2025 Financial Results And Highlights Progress Across Oncology Pipeline
rttnews
Bullish
Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Beats Revenue Estimates
Zacks
Neutral
Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy?
Zacks
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0.5 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BOLT’s Media Buzz Sentiment?
Currently, no data Available
What is BOLT’s weekly average amount of articles?
In an average week, 0.5 articles about BOLT are published.
    What is BOLT’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    DOCSDoximity
    AVAHAveanna Healthcare Holdings
    GOSSGossamer Bio
    CGENCompugen
    SPISpire Healthcare
    Showing the stocks with the most bullish news sentiment over the past week